More Business Wire
View Older Stories View Newer Stories-
KB Home Announces the Grand Opening of Its Newest Community at Summerlin, a Premier Las Vegas Master Plan
-
Keysight Technologies to Participate in Upcoming Investor Conferences
-
Venatorx and Melinta Provide Update on Status of U.S. New Drug Application for Cefepime-Taniborbactam
-
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
-
Dillard’s Introduces The Broke Brooke for Edgehill Collection
-
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial
-
Bento Engine Wins Prestigious WealthBriefing Award
-
KB Home Announces the Grand Opening of Its Newest Community in Desirable Johnstown, Colorado
-
Giant Microelectronics Introduces World’s Smallest and Lowest Power UWB SoC for Precise Ranging, Positioning and Wireless Applications
-
Abridge Emerges as a Healthcare AI Leader, Raising $150M to Accelerate R&D
-
Empire Petroleum Announces Operational Update and Preliminary Financial Results for Fourth Quarter 2023
-
Vecima Announces Turnkey DAA Packages with RocNet Supply, Speeding 10G Deployments for Smaller Operators
-
Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
-
Cresco Labs Continues Retail Expansion in Pennsylvania with New Gettysburg Store
-
Tellurian Reports 2023 Financial Results and Driftwood LNG Progress
-
Popular, Inc. Declares a Cash Dividend of $0.62 per Common Share
-
Missouri Office of Broadband Development Launches Interactive Map Using Sanborn’s Broadband Navigator™ Technology
-
Immunis Chairman Dr. Hans Keirstead is an Invited Speaker at the 2024 Brain Trust Conference
-
Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of T
-
Vertex Receives CHMP Positive Opinion for KALYDECO® for the Treatment of Infants With Cystic Fibrosis Ages 1 Month and Older
-
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
-
Straight Talk Wireless Tax Breaks Event Offers Great Deals and Stress Relief This Tax Season
-
CI Financial Reports Financial Results for the Fourth Quarter of 2023
-
Frontier Reports Fourth-Quarter and Full-Year 2023 Results
-
United Natural Foods Showcases Compelling Solutions to Help Grocery Retail Customers Thrive in Competitive Market
-
iconectiv Recognized for Its Commitment to Simplifying Network Planning and Operational Efficiencies Across Telecom Ecosystem, and Its Support for Streamlining 5G Network Deployments
-
Florida’s Nonprofit State Association and Association of Grantmakers Elevate Florida’s Nonprofit and Philanthropic Community
-
Emerald Announces Date for Fourth Quarter and Full Year 2023 Financial Results Conference Call
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Reblozyl® (luspatercept) for Treatment of Adults with Transfusion-Dependent Anemia due to Low- to Intermediate-Risk Myelodysplastic Syndromes (
-
Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer
-
Hyatt Reports Fourth Quarter and Full Year 2023 Results
-
UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
-
Bloomin’ Brands Announces 2023 Q4 Financial Results
-
Celltrion presents new two-year data for subcutaneous infliximab (CT-P13 SC) in inflammatory bowel disease (IBD) at the 19th ECCO Congress
-
Docebo Reports Fourth Quarter and Fiscal Year 2023 Results
-
CenterOak Partners Announces Sale of SurfacePrep
-
itel Grand 2024 Brand Launch, the Industry's Biggest Event at the Egyptian Pyramids
-
Global Blue Delivers a Strong Q3 FY23/24 Financial Performance, With Continued Double-digit Growth, Healthy Profitability, and Active de-Leveraging
-
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for the Treatment
-
NW Natural Holdings Reports Fourth Quarter and Full Year 2023 Results
-
Nautic Partners Announces Acquisition of SurfacePrep in Partnership With Management
-
Nextdoor Announces Leadership Transition and Reports Preliminary Q4 2023 Financial Results
-
Tikehau Capital: Disclosure of Shares Repurchases from 16 February 2024 to 22 February 2024
-
Westinghouse Welcomes Bulgarian Suppliers to Symposium to Support AP1000® Project Opportunities
-
Vodafone Turkey deploys Adtran optical cesium solution in national timing network
-
Tecnotree Successfully Completes 14 Simultaneous AI and Digital Transformations for Multiple Groups, Across North America, Middle East, Africa and Latam
-
Cloud RAN Networking Solution Between Ataya and Vicinity
-
Mavenir in Commercial Phase of Open RAN Ahead of Large-Scale Deployment for India’s Vodafone Idea
-
TME Pharma Provides Results of Final Exercise of Warrants Y: Additional €854K Raised and Extension of Cash Runway From May Into July 2024
-
Allianz Achieves Record Operating Profit and Shareholders’ Core Net Income

